Reasons for Initiation of Canakinumab of Patients with Systemic Juvenile Idiopathic Arthritis: A Retrospective Medical Chart Review from the United States

被引：0
|
作者：
Hur, Peter [1 ]
Ionescu-Ittu, Raluca [2 ]
Manceur, Ameur M. [2 ]
Lomax, Kathleen G. [1 ]
Cammarota, Jordan [3 ]
Xie, Jipan [4 ]
Sanghera, Navneet [1 ]
Grom, Alexei A. [5 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Anal Grp Inc, Montreal, PQ, Canada
[3] Anal Grp Inc, Washington, DC USA
[4] Anal Grp Inc, Los Angeles, CA USA
[5] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2698
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States
    Hur, Peter
    Lomax, Kathleen G.
    Ionescu-Ittu, Raluca
    Manceur, Ameur M.
    Xie, Jipan
    Cammarota, Jordan
    Gautam, Raju
    Sanghera, Navneet
    Kim, Nina
    Grom, Alexei A.
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [2] Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States
    Peter Hur
    Kathleen G. Lomax
    Raluca Ionescu-Ittu
    Ameur M. Manceur
    Jipan Xie
    Jordan Cammarota
    Raju Gautam
    Navneet Sanghera
    Nina Kim
    Alexei A. Grom
    Pediatric Rheumatology, 19
  • [3] A Retrospective Medical Chart Review of Patients with Periodic Fever Syndromes Initiating Canakinumab in the United States
    Hur, Peter
    Lomax, Kathleen G.
    Ionescu-Ittu, Raluca
    Manceur, Ameur M.
    Xie, Jipan
    Cammarota, Jordan
    Sanghera, Navneet
    Grom, Alexei A.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [4] The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart review
    Shenoi, S.
    Horneff, G.
    Cidon, M.
    Ramanan, A. V.
    Kimura, Y.
    Quartier, P.
    Foeldvari, I.
    Zeft, A.
    Lomax, K. G.
    Gregson, J.
    Abma, T.
    Campbell-Hill, S.
    Weiss, J.
    Patel, D.
    Marinsek, N.
    Wulffraat, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (05) : 920 - 928
  • [5] Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis
    Sun, Haiying
    Van, Linh M.
    Floch, David
    Jiang, Xuemin
    Klein, Ulf R.
    Abrams, Ken
    Sunkara, Gangadhar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1516 - 1527
  • [6] Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review
    Prashanth Sunkureddi
    Dominick Latremouille-Viau
    Mark K. Meiselbach
    Jipan Xie
    Peter Hur
    Reeti Joshi
    Rheumatology and Therapy, 2019, 6 : 89 - 100
  • [7] Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review
    Sunkureddi, Prashanth
    Latremouille-Viau, Dominick
    Meiselbach, Mark K.
    Xie, Jipan
    Hur, Peter
    Joshi, Reeti
    RHEUMATOLOGY AND THERAPY, 2019, 6 (01) : 89 - 100
  • [8] Canakinumab: A Review of Its Use in the Management of Systemic Juvenile Idiopathic Arthritis
    Sheridan M. Hoy
    BioDrugs, 2015, 29 : 133 - 142
  • [9] Canakinumab: A Review of Its Use in the Management of Systemic Juvenile Idiopathic Arthritis
    Hoy, Sheridan M.
    BIODRUGS, 2015, 29 (02) : 133 - 142
  • [10] Temporomandibular joint involvement in patients with juvenile idiopathic arthritis: a retrospective chart review
    von Schuckmann, L.
    Klotsche, J.
    Suling, A.
    Kahl-Nieke, B.
    Foeldvari, I
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2020, 49 (04) : 271 - 280
12345